Biondani, P <br/><br/>
Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  01 2018 
 - 286-287 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx548  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Humans<br/>Liver Transplantation<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Nivolumab--adverse effects<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors